Researchers Develop Dual-Target CRISPR Strategy to Improve Cystic Fibrosis Gene Therapy in Pig Cells
Researchers developed a 'dual-locus-targeting' method using CRISPR/Cas9 and helper-dependent adenoviral vectors to improve the integration of a functional CFTR gene in porcine epithelial cells. The approach targets two genomic sites simultaneously — the CFTR locus and a safe harbour site called GGTA1 — to overcome the low efficiency of the homology-directed repair (HDR) pathway that has historically limited gene replacement therapy for cystic fibrosis. The findings suggest a potential path toward a more universal and permanent gene therapy for CF lung disease, though results remain at the preclinical stage.
Cystic fibrosis (CF) is caused by mutations in the CFTR gene and affects tissues that are difficult to target with gene therapies, making durable treatments elusive. A new preprint study on bioRxiv describes a dual-locus-targeting strategy in which two CRISPR/Cas9-carrying helper-dependent adenoviral vectors (HDAd) are delivered sequentially to porcine epithelial cells — one targeting the native CFTR locus and a second targeting the GGTA1 genomic safe harbour site. This approach was designed to compensate for the inherently low activity of the HDR pathway, which is the cellular mechanism required for precise gene insertion. Using reporter and therapeutic donor genes, the researchers achieved integration efficiencies of 16.5% for a lacZ marker gene and 3.4% for the CFTR gene itself — improvements over single-locus approaches. The study was conducted in porcine cells, which are considered a relevant model for human CF due to physiological similarities in the airway. While the results are promising, the work is a preprint and has not yet undergone peer review, and efficiency levels would likely need further improvement before clinical translation. The authors frame the dual-locus strategy as a foundational step toward a permanent, mutation-agnostic gene replacement therapy for CF.
What's missing
The study does not report data on off-target editing effects at either locus, which is a critical safety consideration for any CRISPR-based therapy. It also does not address whether CFTR expression from the integrated transgene was functional at the protein level or sufficient to restore chloride channel activity. Key open questions include whether the approach can be translated to human airway cells or in vivo models, and whether the GGTA1 safe harbour site has a human equivalent suitable for clinical use.
What different sources said
- bioRxivCenter
A Dual-Locus-Targeting Strategy to Enhance CRISPR/Cas9-mediated CFTR Replacement via Helper-Dependent Adenoviral vector in porcine genome
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.